LYMEPAK

Generic name:doxycycline hyclate
Dosage form: tablet, film coated

Medically reviewed by Drugs.com. Last updated on Sep 1, 2021.

Indications and Usage for LYMEPAK

Early Lyme Disease

LYMEPAK is indicated for the treatment of early Lyme disease (as evidenced by erythema migrans) due to Borrelia burgdorferi in adults and pediatric patients 8 years of age and older weighing 45 kg and above.

Usage

To reduce the development of drug-resistant bacteria and maintain the effectiveness of LYMEPAK and other antibacterial drugs, LYMEPAK should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

LYMEPAK Dosage and Administration

Dosage

Adults and Pediatric Patients 8 years of age and older weighing 45 kg and above

Administer LYMEPAK (100 mg) tablet every 12 hours for 21 days.

Important Administration Instructions

• The usual dosage and frequency of administration of LYMEPAK differs from that of the other tetracyclines. Exceeding the recommended dosage may result in an increased incidence of adverse reactions.
• Administration of adequate amounts of fluid along with the tablets is recommended to wash down the tablet to reduce the risk of esophageal irritation and ulceration [see Adverse Reactions (6)].
• If gastric irritation occurs, LYMEPAK may be given with food or milk. The absorption of doxycycline is not markedly influenced by simultaneous ingestion of food or milk.

Dosage Forms and Strengths

LYMEPAK tablets are green, round, film-coated tablets engraved with LP-1 on one s...